ng-nitroarginine methyl ester has been researched along with Glomerulonephritis, Membranous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miettinen, A; Tikkanen, I; Uhlenius, N; Vuolteenaho, O | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and Glomerulonephritis, Membranous
Article | Year |
---|---|
Renoprotective mechanisms of angiotensin II antagonism in experimental chronic renal failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Autoradiography; Blood Pressure; Body Weight; Captopril; Drinking; Enzyme Inhibitors; Female; Glomerulonephritis; Glomerulonephritis, Membranous; Imidazoles; Kidney; Kidney Failure, Chronic; Microscopy, Fluorescence; NG-Nitroarginine Methyl Ester; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Tetrazoles | 2002 |